Former Executive Director of BD, Fosun Pharma US Former BD head of Kelun Pharmaceutical, Boston 20+ years of experience in drug development and business development, having led the FDA approval of AYVAKYT® (avapritinib) and participated in the approval of GAVRETO® (pralsetinib) Ph.D., Organic Chemistry, Temple University & MBA, Leonard N. Stern School of Business, New York University